ArticleInternational journal of developmental disabilities2025
Complementary and Alternative Medicine in Autism Spectrum Disorder: parents' experience from a middle-income European country.
Article in International journal of developmental disabilities, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study quantitatively evaluated the use and perceived efficacy of Complementary and Alternative Medicine (CAM) treatments among individuals with Autism Spectrum Disorder (ASD) in Macedonia, a middle-income country in Southeast Europe. Methods: A web-based survey was conducted among 103 parents of 103 individuals with ASD, and descriptive statistics and non-parametric tests were used to analyze the data. Results: For the purpose of this study, special diets and the other CAM treatments were analyzed separately. CAMs were used by 76% of the participants with ASD, while 29% were on a special diet. Over 90% of parents positively rated the efficacy of CAM and special diets. Higher parental education was associated with higher CAM use ( Conclusion: This study showed a high prevalence of use of CAM (somewhat lower of special diets) coupled with insufficient familiarity with the attributes of these treatments. Found to affect the use of CAM and/or special diets were the level of parental education, the age of the affected individual, severity of ASD, and the presence of co-occurring neurodevelopmental/neuropsychiatric disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.